Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adsorbed acellular DTaP-Hib combined vaccine in infants and young children
CTR20182419Phase 3Active
- Sponsor
- Beijing Minhai Biological
- Start
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria-tetanus-pertussis and haemophilus influenzae type b combined vaccine in pertussis, diphtheria, Tetanus, Haemophilus influenzae type b disease (Hib), sponsored by Beijing Minhai Biological. Started Apr 2019; status: active.
02
Drugs
diphtheria-tetanus-pertussis and haemophilus influenzae type b combined vaccine
03
Conditions
pertussisdiphtheriaTetanusHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20182419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182419.